Orange Book product · Brand (NDA)
KARBINAL ER
CARBINOXAMINE MALEATE
At a glance
Mar 28, 2013
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 28, 2013
13 yr 5 mo ago
Today
Patent 9522191 expires
Listed drug product patent expiration.
Jun 15, 2027
in 1 yr
Patent 8062667 expires
Listed drug product patent expiration.
Mar 29, 2029
in 2 yr 10 mo
Pharmaceutical detail
Active ingredient
CARBINOXAMINE MALEATE
Strength
4MG/5ML
Dosage form
SUSPENSION, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 022556
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- —CLISTINBrand (NDA)
NDA 008955 · MCNEIL
- —CLISTINBrand (NDA)
NDA 008915 · ORTHO MCNEIL PHARM
- 2024CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 215476 · LEADING
- 2016CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 207484 · MIKART
- 2011CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 090756 · MISSION PHARMACAL
- 2010CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 090417 · CYPRESS PHARM
- 2010CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 090418 · CYPRESS PHARM
- 2010CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 090435 · SENORES PHARMS
- 2008CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 040639 · STRIDES PHARMA INTL
- 2008CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 040814 · PH HEALTH
- 2003CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 040458 · GENUS
- 2003CARBINOXAMINE MALEATEGeneric (ANDA)
ANDA 040442 · GENUS
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9522191 | Jun 15, 2027 | in 1 yr | Product |
| 8062667 | Mar 29, 2029 | in 2 yr 10 mo | Product |

